Establishing Optimal Control Cohorts for Phase 1 Trials: Retrospective Analysis of Clinical and Biological Outcomes in Neonates and Infants Undergoing Two-Ventricle Repair
Pediatric Cardiology · 2025
DOI: 10.1007/s00246-024-03550-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Cardiology, 2025. Verfasst von Kumi Kobayashi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Neuroscience Research and Sheikh Zayed Institute for Pediatric Surgical Innovation, Children's National Hospital, Washington, DC, USA. Hauptthemen laut MEDLINE: Transposition of Great Vessels, Heart Septal Defects, Ventricular, Clinical Trials, Phase I as Topic, Tetralogy of Fallot. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NHLBI NIH HHS, the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program.
Abstract (Originalsprache)
Phase 1 trials are primarily conducted to evaluate the safety and feasibility of new interventions, usually without recruiting control patients. This retrospective study aims to characterize clinical and biological outcomes in historical and contemporary cases of neonates and infants undergoing two-ventricle repair to facilitate future secondary endpoint analyses for such trials. This retrospective study included neonates/infants (ages ≤ 6 months) who underwent two-ventricle repair between 2015 and 2021 using the same criteria as our phase 1 trial (n = 199). Patients were allocated into the ventricular septal defect (n = 61), the Tetralogy of Fallot (TOF, n = 88), and the transposition of the great arteries (n = 50) groups with an additional comparison between two eras (2015-2019 vs. 2020-2021). Patient characteristics and most variables assessed were different between the three diagnostic groups indicating the importance of diagnostic matching for secondary analyses. Although the era did not alter cerebral/somatic oxygenation, ventricular function, neuroimaging findings, and complication rates, we observed improvement of inotropic and/or vasoactive-inotropic scores in all groups during the more recent era. In 2020-2021, the age and the body weight at the operation were higher, and hospital stay was shorter in the TOF group, suggesting the possible impact of the pandemic. Results also indicated that matching altered characteristics such as age at operation that may limit the temporal effects and optimize secondary analyses. Using optimal contemporary cases and historical data based on this study will assist in developing a comprehensive study design for a future efficacy/effectiveness trial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Neuroscience Research and Sheikh Zayed Institute for Pediatric Surgical Innovation, Children's National Hospital, Washington, DC, USA.
- Children's National Heart Center, Children's National Hospital, Washington, DC, 20010, USA.
- Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
- The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.
- Departments of Anesthesiology and Surgery, Harvard Medical School, Boston Children's Hospital, Boston, MA, USA.
- Center for Neuroscience Research and Sheikh Zayed Institute for Pediatric Surgical Innovation, Children's National Hospital, Washington, DC, USA. nishibas@childrensnational.org.
Förderung
- NINDS NIH HHS
- NHLBI NIH HHS
- the Office of the Assistant Secretary of Defense for Health Affairs through the Peer Reviewed Medical Research Program
- NIH HHS
- National Institutes of Health
Zitieren
APA
Kobayashi, K., Kobayashi, K., Liu, C., Ryan, J., Zurakowski, D., & Ishibashi, N. (2025). Establishing Optimal Control Cohorts for Phase 1 Trials: Retrospective Analysis of Clinical and Biological Outcomes in Neonates and Infants Undergoing Two-Ventricle Repair. Pediatric Cardiology. https://doi.org/10.1007/s00246-024-03550-5
Vancouver
Kobayashi K, Kobayashi K, Liu C, Ryan J, Zurakowski D, Ishibashi N. Establishing Optimal Control Cohorts for Phase 1 Trials: Retrospective Analysis of Clinical and Biological Outcomes in Neonates and Infants Undergoing Two-Ventricle Repair. Pediatric Cardiology. 2025. doi:10.1007/s00246-024-03550-5
BibTeX
@article{Kobayashi2025,
author = {Kobayashi, Kumi and Kobayashi, Kei and Liu, Christopher and Ryan, Julia and Zurakowski, David and Ishibashi, Nobuyuki},
title = {Establishing Optimal Control Cohorts for Phase 1 Trials: Retrospective Analysis of Clinical and Biological Outcomes in Neonates and Infants Undergoing Two-Ventricle Repair},
journal = {Pediatric Cardiology},
year = {2025},
doi = {10.1007/s00246-024-03550-5}
}
EUVIMED